The European Union seeks firms for delivery 24 drugs for intensive care, in an effort to solve the problem of shortage of drugs for patients with COVID-19 amid concerns over a possible second wave of illness. About it to Agency Reuters said an unnamed representative of the EU.
The tender, within which will be searched for by medication for the ten member countries of the European Union, requested drug manufacturers to submit proposals by Thursday. This is the last step of the Executive Committee coordinating the procurement of critical drugs, vaccines and equipment for members of the EU in the context of a pandemic COVID-19.
According to the source, the EU is experiencing a shortage of analgesics, antibiotics, muscle relaxants, anaesthetic and resuscitation drugs. The name of the specific drugs in the tender is not indicated, because the procedure is not yet complete.
According to the internal document of the EU, which were journalists from Reuters, in April, the EU lacked about 100 drugs for patients with COVID-19. Among those that are missing or at risk of becoming scarce, paracetamol, fentanyl, midazolam and propofol; resuscitation drugs dobutamine and norepinephrine; muscle relaxants cisatracurium and followed by rocuronium; and the antibiotics piperacillin, azithromycin and amoxicillin.
These drugs are mainly used in the treatment of critically ill patients with COVID-19, the Agency said.
Flash COVID-19 began in late 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
According to data from the American Johns Hopkins University, the total number of infected people in the world exceeded 13.3 million, of which more than 7.39 million recovered, and more 578,6 thousand died.